U.S. Markets open in 1 hr 8 mins

Axonics Modulation Technologies, Inc. (AXNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
51.70-1.05 (-1.99%)
At close: 4:00PM EST

52.93 +1.23 (2.38%)
Before hours: 8:06AM EST

Axonics Modulation Technologies, Inc.

26 Technology Drive
Irvine, CA 92618
United States
949 396 6322
http://www.axonics.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees302

Key Executives

NameTitlePayExercisedYear Born
Mr. Raymond W. CohenCEO & Director871.2kN/A1959
Mr. Danny L. DearenPres & CFO636.2kN/A1963
Mr. Rinda K. SamaChief Operating Officer536.2kN/A1979
Mr. Guangqiang Jiang Ph.D.Chief Technology OfficerN/AN/A1973
Mr. Neil BhalodkarVP of Investor RelationsN/AN/AN/A
Mr. Aaron PettitGen. Counsel & Chief Compliance OfficerN/AN/AN/A
Mr. John Woock Ph.D.Chief Marketing OfficerN/AN/A1983
Mr. Michael V. WilliamsonSr. VP, Gen. & IP CounselN/AN/A1971
Dr. Karen L. Noblett M.D., M.A.S.Chief Medical OfficerN/AN/A1963
Mr. Prabodh MathurChief Product Devel. OfficerN/AN/A1960
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Axonics Modulation Technologies, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems in the United States and internationally. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence, and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company was formerly known as American Restorative Medicine, Inc. and changed its name to Axonics Modulation Technologies, Inc. in August 2013. Axonics Modulation Technologies, Inc. was incorporated in 2012 and is based in Irvine, California.

Corporate Governance

Axonics Modulation Technologies, Inc.’s ISS Governance QualityScore as of December 1, 2020 is 8. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.